Biomerica Total Liab vs Capital Surpluse Analysis

BMRA Stock

USD 0.73 0.03 3.95%

Biomerica financial indicator trend analysis is way more than just evaluating Biomerica prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biomerica is a good investment. Please check the relationship between Biomerica Total Liab and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

Total Liab vs Capital Surpluse

Total Liab vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biomerica Total Liab account and Capital Surpluse. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Biomerica's Total Liab and Capital Surpluse is 0.94. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Biomerica, assuming nothing else is changed. The correlation between historical values of Biomerica's Total Liab and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Biomerica are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Total Liab i.e., Biomerica's Total Liab and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

0.94

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Capital Surpluse

Most indicators from Biomerica's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biomerica current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.At present, Biomerica's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 9.1 M, whereas Selling General Administrative is forecasted to decline to about 6 M.

	2022	2023	2024	2025 (projected)
Gross Profit	446K	611K	549.9K	522.4K
Total Revenue	5.3M	5.4M	6.2M	7.6M

Gross Profit Total Revenue

Biomerica fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Short Long Term Debt Total	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.32	0.68	0.97	0.91	-0.81	-0.52	0.89	0.78	0.45	0.89	0.2	0.4	0.8	0.52	0.68	0.56	0.89	0.62	0.99	0.31	-0.11	0.12	-0.09	0.67	0.49
Other Current Liab	0.32		0.76	0.15	0.14	-0.53	-0.73	0.59	0.03	0.35	0.59	-0.57	0.67	0.15	-0.05	-0.16	0.75	0.54	0.77	0.37	-0.3	-0.36	0.41	0.26	0.28	0.69
Total Current Liabilities	0.68	0.76		0.53	0.59	-0.61	-0.84	0.7	0.43	0.58	0.7	-0.2	0.69	0.65	0.42	0.16	0.79	0.91	0.83	0.7	0.21	-0.31	0.25	-0.06	0.74	0.74
Total Stockholder Equity	0.97	0.15	0.53		0.87	-0.8	-0.34	0.83	0.75	0.31	0.83	0.26	0.21	0.73	0.44	0.73	0.38	0.77	0.45	0.97	0.32	-0.01	0.06	-0.07	0.58	0.32
Property Plant And Equipment Net	0.91	0.14	0.59	0.87		-0.55	-0.51	0.68	0.92	0.58	0.68	0.37	0.42	0.84	0.71	0.64	0.53	0.85	0.6	0.86	0.3	-0.19	0.04	-0.24	0.73	0.47
Net Debt	-0.81	-0.53	-0.61	-0.8	-0.55		0.35	-0.97	-0.33	-0.13	-0.97	0.26	-0.18	-0.51	0.04	-0.44	-0.39	-0.7	-0.48	-0.86	-0.14	-0.1	-0.43	-0.3	-0.28	-0.31
Retained Earnings	-0.52	-0.73	-0.84	-0.34	-0.51	0.35		-0.51	-0.47	-0.57	-0.51	0.12	-0.95	-0.46	-0.6	0.0	-0.97	-0.73	-0.94	-0.5	0.1	0.61	0.1	0.39	-0.78	-0.96
Cash	0.89	0.59	0.7	0.83	0.68	-0.97	-0.51		0.48	0.31	1.0	-0.17	0.39	0.63	0.16	0.49	0.57	0.81	0.66	0.92	0.15	-0.04	0.39	0.2	0.42	0.49
Non Current Assets Total	0.78	0.03	0.43	0.75	0.92	-0.33	-0.47	0.48		0.5	0.48	0.5	0.44	0.69	0.78	0.54	0.51	0.68	0.55	0.7	0.17	-0.25	-0.14	-0.34	0.69	0.47
Non Currrent Assets Other	0.45	0.35	0.58	0.31	0.58	-0.13	-0.57	0.31	0.5		0.31	0.23	0.59	0.63	0.64	0.27	0.6	0.64	0.52	0.42	0.13	-0.23	0.17	-0.09	0.58	0.58
Cash And Short Term Investments	0.89	0.59	0.7	0.83	0.68	-0.97	-0.51	1.0	0.48	0.31		-0.17	0.39	0.63	0.16	0.49	0.57	0.81	0.66	0.92	0.15	-0.04	0.39	0.2	0.42	0.49
Net Receivables	0.2	-0.57	-0.2	0.26	0.37	0.26	0.12	-0.17	0.5	0.23	-0.17		-0.04	0.43	0.55	0.55	-0.09	0.04	-0.16	0.13	0.44	-0.07	-0.5	-0.43	0.22	-0.05
Common Stock Shares Outstanding	0.4	0.67	0.69	0.21	0.42	-0.18	-0.95	0.39	0.44	0.59	0.39	-0.04		0.38	0.62	0.0	0.97	0.58	0.91	0.37	-0.16	-0.65	-0.17	-0.42	0.69	0.99
Non Current Liabilities Total	0.8	0.15	0.65	0.73	0.84	-0.51	-0.46	0.63	0.69	0.63	0.63	0.43	0.38		0.63	0.6	0.48	0.84	0.51	0.78	0.64	-0.03	0.14	-0.17	0.66	0.44
Inventory	0.52	-0.05	0.42	0.44	0.71	0.04	-0.6	0.16	0.78	0.64	0.16	0.55	0.62	0.63		0.38	0.59	0.56	0.52	0.44	0.28	-0.44	-0.46	-0.71	0.84	0.62
Other Current Assets	0.68	-0.16	0.16	0.73	0.64	-0.44	0.0	0.49	0.54	0.27	0.49	0.55	0.0	0.6	0.38		0.08	0.44	0.13	0.67	0.53	0.03	-0.13	-0.15	0.25	0.06
Other Stockholder Equity	0.56	0.75	0.79	0.38	0.53	-0.39	-0.97	0.57	0.51	0.6	0.57	-0.09	0.97	0.48	0.59	0.08		0.71	0.97	0.54	-0.13	-0.6	-0.03	-0.31	0.71	0.99
Total Liab	0.89	0.54	0.91	0.77	0.85	-0.7	-0.73	0.81	0.68	0.64	0.81	0.04	0.58	0.84	0.56	0.44	0.71		0.78	0.88	0.34	-0.2	0.25	-0.08	0.78	0.64
Property Plant And Equipment Gross	0.62	0.77	0.83	0.45	0.6	-0.48	-0.94	0.66	0.55	0.52	0.66	-0.16	0.91	0.51	0.52	0.13	0.97	0.78		0.6	-0.1	-0.56	0.07	-0.23	0.69	0.93
Total Current Assets	0.99	0.37	0.7	0.97	0.86	-0.86	-0.5	0.92	0.7	0.42	0.92	0.13	0.37	0.78	0.44	0.67	0.54	0.88	0.6		0.32	-0.07	0.17	-0.03	0.63	0.47
Accounts Payable	0.31	-0.3	0.21	0.32	0.3	-0.14	0.1	0.15	0.17	0.13	0.15	0.44	-0.16	0.64	0.28	0.53	-0.13	0.34	-0.1	0.32		0.39	0.0	-0.16	0.24	-0.11
Short Long Term Debt Total	-0.11	-0.36	-0.31	-0.01	-0.19	-0.1	0.61	-0.04	-0.25	-0.23	-0.04	-0.07	-0.65	-0.03	-0.44	0.03	-0.6	-0.2	-0.56	-0.07	0.39		0.49	0.54	-0.41	-0.62
Short Term Debt	0.12	0.41	0.25	0.06	0.04	-0.43	0.1	0.39	-0.14	0.17	0.39	-0.5	-0.17	0.14	-0.46	-0.13	-0.03	0.25	0.07	0.17	0.0	0.49		0.88	-0.29	-0.15
Intangible Assets	-0.09	0.26	-0.06	-0.07	-0.24	-0.3	0.39	0.2	-0.34	-0.09	0.2	-0.43	-0.42	-0.17	-0.71	-0.15	-0.31	-0.08	-0.23	-0.03	-0.16	0.54	0.88		-0.58	-0.4
Common Stock Total Equity	0.67	0.28	0.74	0.58	0.73	-0.28	-0.78	0.42	0.69	0.58	0.42	0.22	0.69	0.66	0.84	0.25	0.71	0.78	0.69	0.63	0.24	-0.41	-0.29	-0.58		0.72
Common Stock	0.49	0.69	0.74	0.32	0.47	-0.31	-0.96	0.49	0.47	0.58	0.49	-0.05	0.99	0.44	0.62	0.06	0.99	0.64	0.93	0.47	-0.11	-0.62	-0.15	-0.4	0.72

Click cells to compare fundamentals

Biomerica Account Relationship Matchups

Biomerica fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	11.8M	11.4M	14.5M	9.3M	10.6M	7.4M
Other Current Liab	213.3K	848.6K	1.2M	1.5M	1.4M	1.4M
Total Current Liabilities	1.3M	2.0M	1.9M	2.2M	2.0M	1.3M
Total Stockholder Equity	9.2M	8.3M	11.7M	6.6M	7.6M	4.5M
Property Plant And Equipment Net	1.9M	1.5M	1.2M	943K	1.1M	693.1K
Net Debt	(2.6M)	(4.5M)	(8.6M)	(3.4M)	(3.0M)	(2.9M)
Retained Earnings	(28.4M)	(35.1M)	(42.2M)	(48.2M)	(43.4M)	(41.2M)
Cash	4.2M	5.9M	9.7M	4.2M	4.8M	5.0M
Non Current Assets Total	2.6M	1.9M	1.7M	1.5M	1.8M	1.4M
Non Currrent Assets Other	264.2K	95.6K	79K	203K	182.7K	166.8K
Cash And Short Term Investments	4.2M	5.9M	9.7M	4.2M	4.8M	5.0M
Net Receivables	1.5M	773.8K	722K	947K	852.3K	950.1K
Common Stock Shares Outstanding	11.9M	12.7M	14.2M	16.8M	19.3M	20.3M
Liabilities And Stockholders Equity	11.8M	11.4M	14.5M	9.3M	10.6M	7.4M
Non Current Liabilities Total	1.3M	1.0M	785K	459K	527.9K	501.5K
Inventory	3.2M	2.4M	2.1M	2.4M	2.7M	2.2M
Other Current Assets	370.3K	320.7K	300K	238K	214.2K	285.8K
Other Stockholder Equity	38.8M	42.4M	52.7M	53.5M	61.6M	64.7M
Total Liab	2.6M	3.0M	2.7M	2.7M	2.4M	1.5M
Property Plant And Equipment Gross	1.9M	3.5M	3.2M	3.2M	3.7M	3.9M
Total Current Assets	9.2M	9.4M	12.8M	7.7M	8.9M	6.0M
Accumulated Other Comprehensive Income	(48.0K)	(73.9K)	(110K)	(102K)	(117.3K)	(123.2K)
Accounts Payable	431K	736K	344K	288K	259.2K	246.2K
Short Long Term Debt Total	1.6M	1.4M	1.1M	785K	706.5K	688.4K
Short Term Debt	655.9K	682.3K	297K	326K	293.4K	476.5K
Intangible Assets	294.8K	170K	165K	212K	190.8K	273.3K
Common Stock	939.2K	984.6K	1.0M	1.3M	1.5M	1.6M
Other Assets	168.2K	264.2K	363.0	79K	90.9K	86.3K
Property Plant Equipment	2.0M	1.9M	1.5M	1.2M	1.4M	1.5M
Net Tangible Assets	14.0M	8.9M	8.2M	11.6M	13.3M	7.8M
Net Invested Capital	9.2M	8.3M	11.7M	6.6M	7.6M	8.6M
Net Working Capital	7.9M	7.4M	10.9M	5.5M	6.4M	7.6M
Capital Stock	964.9K	984.6K	1.0M	1.3M	1.5M	1.2M
Capital Lease Obligations	1.6M	1.4M	1.1M	785K	706.5K	1.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:

How To Invest In Biomerica

Details

Is Biomerica Stock a good investment?

Details

What is Biomerica's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.37)

Revenue Per Share

0.327

Quarterly Revenue Growth

0.055

Return On Assets

(0.39)

Return On Equity

(0.76)

The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biomerica Total Liab vs Capital Surpluse Analysis

Total Liab vs Capital Surpluse

Total Liab vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Total Liab

Capital Surpluse

Biomerica fundamental ratios Correlations

Biomerica Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biomerica fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 0.99	Total Assets
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Other Stockholder Equity
Total Stockholder Equity	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Total Stockholder Equity

Other Stockholder Equity	- 0.97	Retained Earnings
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Common Stock	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Property Plant And Equipment Gross	- 0.94	Retained Earnings